Masatsugu Okamura

Dr. Masatsugu Okamura

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2023 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
MOMasatsugu Okamura
Masatsugu Okamura
MKMasaaki Konishi
Masaaki Konishi
JBJaved Butler
Javed Butler
KKKamyar Kalantar‐Zadeh
Kamyar Kalantar‐Zadeh
SHStephan von Haehling
Stephan von Haehling
SAStefan D. Anker
Stefan D. Anker
Cachexia, in the form of unintentional weight loss >5% in 12 months or less, and secondary sarcopenia in the form of muscle wasting are serious conditions that affect clinical outcomes. A chronic disease state such as chronic kidney disease (CKD) often contributes to these wasting disorders. The purpose of this review is to summarize the prevalence of cachexia and sarcopenia, their relationship with kidney function, and indicators for evaluating kidney function in patients with CKD. It is estimated that approximately half of all persons with CKD will develop cachexia with an estimated annual mortality rate of 20%, but few studies have been conducted on cachexia in CKD. Hence, the true prevalence of cachexia in CKD and its effects on kidney function and patient outcomes remain unclear. Some studies have highlighted the concept of protein‐energy wasting (PEW) which usually include sarcopenia and cachexia. Several studies have examined kidney function and CKD progression in patients with sarcopenia. Most studies use serum creatinine levels to estimate kidney function. However, creatinine may be influenced by muscle mass, and creatinine‐based glomerular filtration rate may overestimate kidney function in patients with reduced muscle mass or muscle wasting. Cystatin C, which is least affected by muscle mass, has been used in some studies, and creatinine‐to‐cystatin‐C ratio has emerged as an important prognostic marker. A previous study incorporating 428 320 participants reported that participants with CKD and sarcopenia had a 33% higher hazard of mortality compared with those without (7% to 66%, P = 0.011), and that those with sarcopenia were twice as likely to develop end‐stage kidney disease (hazard ratio: 1.98; 1.45 to 2.70, P < 0.001). Future studies on cachexia and sarcopenia in patients with CKD are needed to report rigorously defined cachexia concerning kidney function. Moreover, in studies on sarcopenia with CKD, it is desirable to accumulate studies using cystatin C to accurately estimate kidney function.

6 August 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
NSNobuyuki Shirai
Nobuyuki Shirai
Tatsuro InoueTatsuro Inoue
Tatsuro Inoue
MOMasato Ogawa
Masato Ogawa
MOMasatsugu Okamura
Masatsugu Okamura
SMShinichiro Morishita
Shinichiro Morishita
ATAtsuhiro Tsubaki
Atsuhiro Tsubaki
Falls are a social problem that increase healthcare costs. Hemodialysis (HD) patients need to avoid falling because fractures increase their risk of death. Nutritional problems such as frailty, sarcopenia, undernutrition, protein-energy wasting (PEW), and cachexia may increase the risk of falls and fractures in patients with HD. This review aimed to summarize the impact of frailty, sarcopenia, undernutrition, PEW, and cachexia on falls in HD patients. The reported global incidence of falls in HD patients is 0.85–1.60 falls per patient per year. HD patients fall frequently, but few reports have investigated the relationship between nutrition-related problems and falls. Several studies reported that frailty and undernutrition increase the risk of falls in HD patients. Nutritional therapy may help to prevent falls in HD patients. HD patients’ falls are caused by nutritional problems such as iatrogenic and non-iatrogenic factors. Falls increase a person’s fear of falling, reducing physical activity, which then causes muscle weakness and further decreased physical activity; this cycle can cause multiple falls. Further research is necessary to clarify the relationships between falls and sarcopenia, cachexia, and PEW. Routine clinical assessments of nutrition-related problems are crucial to prevent falls in HD patients.

1 June 2021 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
Nobuto NakanishiNobuto Nakanishi
Nobuto Nakanishi
KOKazuki Okura
Kazuki Okura
MOMasatsugu Okamura
Masatsugu Okamura
KNKeishi Nawata
Keishi Nawata
ASAyato Shinohara
Ayato Shinohara
SKSho Katayama
Sho Katayama

9 November 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
MOMasatsugu Okamura
Masatsugu Okamura
Tatsuro InoueTatsuro Inoue
Tatsuro Inoue
MOMasato Ogawa
Masato Ogawa
Kengo ShiradoKengo Shirado
Kengo Shirado
NSNobuyuki Shirai
Nobuyuki Shirai
YOJI KOKURAYOJI KOKURA
YOJI KOKURA
Rehabilitation nutrition is a proposed intervention strategy to improve nutritional status and physical function. However, rehabilitation nutrition in patients with cachexia and protein-energy wasting (PEW), which are the main nutrition-related problems in patients with chronic kidney disease (CKD), has not been fully clarified. Therefore, this review aimed to summarize the current evidence and interventions related to rehabilitation nutrition for cachexia and PEW in patients with CKD. CKD is a serious condition worldwide, with a significant impact on patient prognosis. In addition, CKD is easily complicated by nutrition-related problems such as cachexia and PEW owing to disease background- and treatment-related factors, which can further worsen the prognosis. Although nutritional management and exercise therapy are reportedly effective for cachexia and PEW, the effectiveness of combined nutrition and exercise interventions is less clear. In the future, rehabilitation nutrition addressing the nutritional problems associated with CKD will become more widespread as more scientific evidence accumulates. In clinical practice, early intervention in patients with CKD involving both nutrition and exercise after appropriate assessment may be necessary to improve patient outcomes.


23 December 2021 in Medicine
Verified
Journal Article
Open access
MOMasatsugu Okamura
Masatsugu Okamura
MKMasaaki Konishi
Masaaki Konishi
ASAkiko Sagara
Akiko Sagara
YSYasuo Shimizu
Yasuo Shimizu
TNTakeshi Nakamura
Takeshi Nakamura
Whereas early rehabilitation improves the patients’ physical function in patients with cerebral infarction and hemorrhage, complications in the early stage are the main barriers in patients with subarachnoid hemorrhage (SAH). Therefore, the clinical impact of early rehabilitation in patients with SAH is not well documented. We sought to investigate whether early mobilization is associated with favorable discharge disposition and functional status in patients with SAH. Hospitalization data of 35 patients (65.7 ± 13.7 years, 37.1% men) were retrospectively reviewed. The early and delayed mobilization groups were defined as those who had and had not participated in walking rehabilitation on day 14, respectively. We investigated whether patients were discharged or transferred to another hospital and assessed their functional status using the Functional Ambulation Categories, Ambulation Index, Glasgow Outcome Scale, and modified Rankin Scale scores. Nine patients (69.2%) in the early mobilization group and one patient (4.5%) in the delayed mobilization group were discharged home directly (P < .001). In multivariate logistic regression analysis, early mobilization was independently associated with home discharge after adjustment using the World Federation of Neurosurgical Societies grade (adjusted odds ratio = 30.20, 95% CI = 2.77–329.00, P < .01). Early mobilization was associated with favorable functional status at discharge through multivariate linear regression analysis (standardized beta = 0.64 with P < .001 for the Functional Ambulation Category and beta = -0.62 with P < .001 for the modified Rankin Scale, respectively). Early mobilization was associated with home discharge and favorable functional status at discharge. Larger prospective studies are warranted.